Shanghai Pharmaceuticals Holding Co (S1R) Financial Statements
Shanghai Pharmaceuticals Holding Co Financial Overview
Shanghai Pharmaceuticals Holding Co's market cap is currently $7.35B. The company's EPS TTM is $1.38; its P/E ratio is 12.05; and it has a dividend yield of 5.44%. Shanghai Pharmaceuticals Holding Co is estimated to report earnings on April 1, 2027, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 283.58B | $ 275.25B | $ 260.30B | $ 231.98B | $ 215.82B |
| Gross Profit | $ 30.42B | $ 30.63B | $ 30.93B | $ 30.49B | $ 28.54B |
| Operating Income | $ 9.94B | $ 8.14B | $ 7.67B | $ 9.01B | $ 8.21B |
| EBITDA | $ 14.37B | $ 12.06B | $ 10.90B | $ 12.44B | $ 10.55B |
| Net Income | $ 5.72B | $ 4.55B | $ 3.77B | $ 5.62B | $ 5.09B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 43.08B | $ 44.38B | $ 40.67B | $ 37.01B | $ 22.39B |
| Total Assets | $ 233.15B | $ 221.21B | $ 211.97B | $ 198.13B | $ 163.44B |
| Total Debt | $ 49.48B | $ 47.79B | $ 42.90B | $ 38.56B | $ 31.69B |
| Net Debt | $ 16.76B | $ 12.05B | $ 12.38B | $ 11.16B | $ 9.30B |
| Total Liabilities | $ 143.36B | $ 137.47B | $ 131.65B | $ 120.13B | $ 104.37B |
| Stockholders' Equity | $ 75.89B | $ 71.68B | $ 68.52B | $ 67.06B | $ 49.36B |
| Cash Flow | |||||
| Free Cash Flow | $ 3.83B | $ 3.43B | $ 2.26B | $ 2.06B | $ 942.55M |
| Operating Cash Flow | $ 6.15B | $ 5.83B | $ 5.23B | $ 4.74B | $ 5.06B |
| Investing Cash Flow | $ -3.98B | $ 415.98M | $ -2.49B | $ -12.47B | $ -6.02B |
| Financing Cash Flow | $ -5.65B | $ -1.86B | $ 231.85M | $ 12.14B | $ 1.57B |
Currency in CNY
